• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX, INC. AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX, INC. AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA28-90/I20-30
Device Problems Leak/Splash (1354); Stretched (1601)
Patient Problem Failure of Implant (1924)
Event Date 11/28/2017
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with a bifurcated stent, an infrarenal aortic extension and a non-endologix gore thoracic device.A follow up computed tomography (ct) showed the patient had a type 1a endoleak and possible dilation of the main body stent at the distal region.The physician elected to implant an additional bifurcated stent and an additional infrarenal aortic extension.During the secondary procedure the physician extended coverage by covering the sma, celiac and renal arteries.Additional non-endologix stents were implanted snorkel the covered arteries.The final patient status is unknown and not initially reported.There have been no additional adverse events reported for this patient.
 
Manufacturer Narrative
Based on the information received at the completion of the clinical evaluation, there were substantial reported evidence that supported the following case event.Clinical confirmed the secondary endovascular procedure performed on (b)(6) 2017.The patient condition post repair was favorable.Upon refuted findings from clinical assessment, the reported type 1a was resolved, but there was a persistent gutter leak seen at the end of the repair procedure, and, one day post procedure, an indeterminate (type iii) endoleak was noted.The type 1a and stent cage dilation was not able to be confirmed by clinical due to lack of medical images.The reported implant migration/movement was not confirmed because the graft movement was related to a non-endologix device (gore).Cumulative knowledge informed by past assessments of similar complaints was applied to a review of the available medical information.The most likely cause of the compromised stent graft integrity of the main body (stretched -~20%) was the use of strata material in combination with the use of non endologix products (intentional user-error) and large balloon dilation at implant.The most likely proximal loss of seal was the concomitant thoracic aneurysm (cautionary product use).Procedure-related harms included bilateral renal infarcts due to the planned, intentional covering of the renal arteries, and blood chemistry abnormalities.The patient was discharged home on the fifth post operative day with a known, persistent indeterminate endoleak.A review of the manufacturing lot confirmed all devices met specifications prior to release.The devices remain implanted in the patient and will not returned and no evaluation will be completed.These types of events will be monitored and trended as part of the quality system.
 
Event Description
Upon refuted findings from clinical assessment, the reported type 1a was resolved, but there was a persistent gutter leak seen at the end of the repair procedure, and, one day post procedure, an indeterminate (type iii) endoleak was noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX, INC.
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key7153070
MDR Text Key96001664
Report Number2031527-2017-00704
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date12/31/2013
Device Model NumberBA28-90/I20-30
Device Lot Number1101184-005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/28/2017
Initial Date FDA Received12/28/2017
Supplement Dates Manufacturer Received11/28/2017
Supplement Dates FDA Received04/04/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/11/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-